XML 63 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
12 Months Ended
Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based awards outstanding by award type
As of July 31, 2024, the following stock-based awards, by award type, were outstanding:
 July 31, 2024
Stock options141,190 
Performance shares380,680 
RSUs, restricted stock, share units and other stock-based awards1,419,608 
Total1,941,478 
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Consolidated Statements of Operations:
 Fiscal Years Ended July 31,
 202420232022
Cost of sales$778,000 1,110,000 692,000 
Selling, general and administrative expenses4,777,000 7,960,000 6,312,000 
Research and development expenses541,000 1,037,000 763,000 
Stock-based compensation expense before CEO transition
     costs
6,096,000 10,107,000 7,767,000 
CEO transition costs related to equity-classified stock-based
     awards
— 3,764,000 7,388,000 
Total stock-based compensation expense before income tax
     benefit
6,096,000 13,871,000 15,155,000 
Estimated income tax benefit(1,298,000)(2,552,000)(2,260,000)
Net stock-based compensation expense$4,798,000 11,319,000 12,895,000 
Summary of stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
Fiscal Years Ended July 31,
202420232022
Stock options$60,000 87,000 519,000 
Performance shares480,000 973,000 1,136,000 
RSUs, restricted stock, share units and other stock-based awards5,477,000 8,926,000 5,912,000 
ESPP79,000 121,000 200,000 
Stock based compensation expense before CEO transition costs6,096,000 10,107,000 7,767,000 
CEO transition costs related to equity-classified stock-based
    awards
— 3,764,000 7,388,000 
Total stock-based compensation expense before income tax benefit6,096,000 13,871,000 15,155,000 
Estimated income tax benefit(1,298,000)(2,552,000)(2,260,000)
Net stock-based compensation expense$4,798,000 11,319,000 12,895,000 
Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity:
 Awards
(in Shares)
Weighted Average
Exercise Price
Weighted Average
Remaining Contractual
Term (Years)
Aggregate
Intrinsic Value
Outstanding at July 31, 20211,073,435 $25.76   
Expired/canceled(588,735)26.86   
Exercised(1,220)17.88 
Outstanding at July 31, 2022483,480 24.43 
Expired/canceled(242,970)24.89 
Outstanding at July 31, 2023240,510 23.96 
Expired/canceled(99,320)28.72 
Outstanding at July 31, 2024141,190 $20.61 4.51$— 
Exercisable at July 31, 2024129,840 $20.84 4.39$— 
Vested and expected to vest at July 31, 2024139,975 $20.63 4.50$— 
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock, share units and other stock-based awards:
  Awards
(in Shares)
 Weighted Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2021 1,068,370 $21.93 
Granted 797,771 18.77 
Settled (641,747)22.83 
Canceled/Forfeited (113,644)22.78 
Outstanding at July 31, 20221,110,750 19.05 
Granted1,550,951 10.79 
Settled(632,267)16.69 
Canceled/Forfeited(153,204)16.67 
Outstanding at July 31, 2023 1,876,230 13.21 
Granted1,731,760 6.71 
Settled(1,042,860)9.77 
Canceled/Forfeited(764,842)9.28 
Outstanding at July 31, 20241,800,288 $10.61 $5,833,000 
  
Vested at July 31, 2024 583,209 $12.30 $1,890,000 
  
Vested and expected to vest at July 31, 2024 1,739,662 $10.61 $5,637,000